PFA Intimation w.r.t grant and cancellation of ESOPs

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+5.9%1-day move

₹2900.00

prior close

₹2958.10

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2+0.6+0.6+1.6+5.9+4.6+5.2+6.4+7.8+9.6+4.3+2.4+16.4—

Up moveDown movePending

AI summary

Ajanta Pharma's Nomination and Remuneration Committee has granted 145,000 stock options to employees under the Ajanta Pharma Share Based Incentive Plan 2019. Each option covers one share with an exercise period of three months from vesting date. Additionally, 850 stock options were cancelled and credited back to the ESOP pool. This is a routine disclosure under SEBI Listing Regulations.

Likely market impact

This is a standard ESOP-related disclosure with minimal direct impact on share price. The grant represents potential dilution of 145,000 shares when exercised, though spread over time this is typically not material for share price movement.